A group of Egyptian researchers also concluded that NGAL is a parameter that is elevated in patients with SLE who had manifested LN, as well as in those who did not manifest active LNephritis, while the control group had a statistically significantly lower level of NGAL in urine [33]. This evidence concerns the gene LCN2 and lobular neoplasia.